Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis

BACKGROUND: Brivaracetam (BRV), cenobamate (CNB), eslicarbazepine acetate (ESL), lacosamide (LCM) and perampanel (PER) are antiseizure medications (ASMs) approved for adjunctive treatment of focal-onset seizures. So far, no randomised controlled trial directly compared the efficacy and safety of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lattanzi, Simona, Trinka, Eugen, Zaccara, Gaetano, Striano, Pasquale, Russo, Emilio, Del Giovane, Cinzia, Silvestrini, Mauro, Brigo, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843918/
https://www.ncbi.nlm.nih.gov/pubmed/35061214
http://dx.doi.org/10.1007/s40265-021-01661-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843918/
https://www.ncbi.nlm.nih.gov/pubmed/35061214
http://dx.doi.org/10.1007/s40265-021-01661-4

Ejemplares similares